A newly approved medicine enters the market after successful clinical trials. After thousands of patients start using it, healthcare professionals report unexpected liver-related side effects. Pharmacovigilance teams collect, assess, and analyze these reports. If a significant safety risk is identified, regulatory authorities may update warning labels or issue safety communications.